Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 43 Prostatic Neoplasms 41 Carcinoma, Non-Small-Cell Lung 36 Breast Neoplasms 34 Lymphoma 28 Leukemia, Myeloid, Acute 25 Lymphoma, Non-Hodgkin 21 Melanoma 18 Colorectal Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Ovarian Neoplasms 15 Lung Neoplasms 15 Hodgkin Disease 15 Hematologic Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 13 Neoplasms 13 Neoplasm Metastasis 13 Myelodysplastic Syndromes 13 Sarcoma 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Wilms Tumor 11 Head and Neck Neoplasms 11 Carcinoma, Renal Cell 11 Burkitt Lymphoma 11 Triple Negative Breast Neoplasms 10 Pancreatic Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 9 Leukemia 9 Glioma 9 Fallopian Tube Neoplasms 9

Interventions

pomalidomide 1 daratumumab 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Plasmacytoma × 30 days × Clear all

NCT01946477 2026-05-22

POM MM 014

Celgene

Phase 2 Completed

186 enrolled 17 charts

Multiple Myeloma, Neoplasms, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡